タンパク質発現の市場規模、シェア、動向分析レポート：発現システム別、製品別、最終用途別、地域別、およびセグメント予測、2024年～2030年

タンパク質発現市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のタンパク質発現市場規模は2030年までに65億1,000万米ドルに達し、2024～2030年のCAGRは10.22％で拡大すると予測されています。

プロテオミクスとゲノミクスの研究の増加、慢性疾患の罹患率の上昇、世界の生物製剤の需要の高まりが、タンパク質発現の需要を高めており、これが市場を牽引する可能性が高いです。例えば、2022年4月、Frontiers Media S.A.に掲載された調査では、研究者は多発性硬化症（MS）の潜在的な診断バイオマーカーを特定するために22のタンパク質を差次的に発現させました。

各社による研究開発投資の増加は、タンパク質発現の利用にかなりの影響を与えると推定されます。2022年8月、Biocon Biologicsのマネージング・ディレクターはあるインタビューの中で、研究開発にかかる総コストは収益の12～14％であると述べた。この投資は、約20のバイオシミラー分子からなるサステイナブルポートフォリオを構築するために不可欠であり、同社は少なくとも1～2年に1回は上市すると予想されています。これらの分子開発にかかるおおよそのコストは5,000万～1億米ドルです。

タンパク質治療に対する需要の急速な加速や、タンパク質発現産業の応用に対する政府の投資といったその他の決定要因も、市場の成長を支えています。例えば、2022年5月、Proteomics International Laboratoriesは、オーストラリア政府から医療研究未来基金（MRFF）イニシアティブの下、約28万6,833米ドルの資金を獲得しました。この資金は、オーストラリアにおけるPromarkerD試験の製造を支援するものと期待されています。このような資金援助は、今後数年間の市場成長を補完するものと考えられます。

COVID-19パンデミックの発生は、COVID-19患者のプロファイリングと遺伝子発現の差分解析を実施する必要性を高めました。2021年3月、Briefings in Bioinformaticsに掲載された調査では、COVID-19の治療を特定するためにタンパク質-薬剤相互作用のデータが用いられました。その結果、COVID-19パンデミックの間、このプロセスの利用が急増し、市場成長に寄与すると予測されます。

個別化治療とワクチンに対する要求の高まりは、予測期間中の市場成長を促進する主要因になると予想されます。例えば、2022年1月、AmgenはGenerate Biomedicinesとの提携を発表し、様々なセグメントのタンパク質治療の発見と開発に取り組んでいます。両社はこの提携の価値を19億米ドル程度と見積もっています。

飲食品の生産など工業用途での組換えタンパク質の開発が増加していることから、医療以外のセグメントでのタンパク質発現の利用が促進されると予想されます。しかし、工業用と医薬品用の組換えタンパク質の小売価格は大きく異なり、医薬品用タンパク質は1kgあたり数10億米ドルで販売されるのに対し、工業用タンパク質は1kgあたり数十ドルです。医薬品用タンパク質には、研究開発、臨床試験、特許が追加で必要となります。

タンパク質発現市場レポートハイライト

• 原核生物セグメントは2023年に41.37%の最大市場シェアを占めました。原核生物は比較的扱いやすく、研究の主要な目的を果たします。
• 2023年には、試薬が44.44%のトップシェアを占めました。同市場は、Agilent Technologies, Inc.などの成熟した参入企業で構成されています。
• 2023年には、治療セグメントが52.05％で最も高い市場シェアを占めました。タンパク質治療は、他の薬よりも多くの利点をもたらすため、2023年の市場シェアは52.05%と最も高いです。
• 製薬・バイオテクノロジー企業セグメントは、2023年に46.50％で最大の市場シェアを占めました。
• 北米のタンパク質発現市場は、2023年に36.11％のシェアで世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 タンパク質発現市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• タンパク質発現市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 タンパク質発現市場： 発現システム別、推定・動向分析

• セグメントダッシュボード
• 世界のタンパク質発現市場発現システムの変動分析
• 世界のタンパク質発現市場規模と動向分析、発現システム別、2018～2030年
• 原核生物
• 哺乳類細胞
• 昆虫細胞
• 酵母
• その他

第5章 タンパク質発現市場：製品別、推定・動向分析

• セグメントダッシュボード
• 世界のタンパク質発現市場の製品変動分析
• 世界のタンパク質発現市場規模と動向分析、製品別、2018～2030年
• 試薬
• コンピテントセル
• 発現ベクター
• サービス
• 機器

第6章 タンパク質発現市場：用途別、推定・動向分析

• セグメントダッシュボード
• 世界のタンパク質発現市場の用途変動分析
• 世界のタンパク質発現市場規模と動向分析、用途別、2018～2030年
• 治療
  • 2018～2030年の治療市場推定・予測
• 産業
  • 2018～2030年の産業市場推定・予測
• 研究
  • 2018～2030年の研究市場推定・予測

第7章 タンパク質発現市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界のタンパク質発現市場の最終用途変動分析
• 世界のタンパク質発現市場規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
• 学術研究
• 委託研究機関
• その他

第8章 タンパク質発現市場：発現システム、製品、用途、最終用途別の地域別、推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • Edward Lifesciences
  • Thermo Fisher Scientific, Inc.
  • Merck Millipore
  • New England BioLabs, Inc.
  • Promega Corporation
  • QIAGEN
  • Takara Bio, Inc.
  • Oxford Expression Technologies
  • Lucigen Corporation

List of Tables

• Table 1 List of abbreviation
• Table 2 Global protein expression market, by region, 2018 - 2030 (USD Million)
• Table 3 Global protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 4 Global protein expression market, by product, 2018 - 2030 (USD Million)
• Table 5 Global protein expression market, by application, 2018 - 2030 (USD Million)
• Table 6 Global protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 7 North America protein expression market, by country, 2018 - 2030 (USD Million)
• Table 8 North America protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 9 North America protein expression market, by product, 2018 - 2030 (USD Million)
• Table 10 North America protein expression market, by application, 2018 - 2030 (USD Million)
• Table 11 North America protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 12 U.S. protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 13 U.S. protein expression market, by product, 2018 - 2030 (USD Million)
• Table 14 U.S. protein expression market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 16 Canada protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 17 Canada protein expression market, by product, 2018 - 2030 (USD Million)
• Table 18 Canada protein expression market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 20 Mexico protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 21 Mexico protein expression market, by product, 2018 - 2030 (USD Million)
• Table 22 Mexico protein expression market, by application, 2018 - 2030 (USD Million)
• Table 23 Mexico protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 24 Europe protein expression market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 26 Europe protein expression market, by product, 2018 - 2030 (USD Million)
• Table 27 Europe protein expression market, by application, 2018 - 2030 (USD Million)
• Table 28 Europe protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 29 Germany protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 30 Germany protein expression market, by product, 2018 - 2030 (USD Million)
• Table 31 Germany protein expression market, by application, 2018 - 2030 (USD Million)
• Table 32 Germany protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 33 UK protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 34 UK protein expression market, by product, 2018 - 2030 (USD Million)
• Table 35 UK protein expression market, by application, 2018 - 2030 (USD Million)
• Table 36 UK protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 37 France protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 38 France protein expression market, by product, 2018 - 2030 (USD Million)
• Table 39 France protein expression market, by application, 2018 - 2030 (USD Million)
• Table 40 France protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 41 Italy protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 42 Italy protein expression market, by product, 2018 - 2030 (USD Million)
• Table 43 Italy protein expression market, by application, 2018 - 2030 (USD Million)
• Table 44 Italy protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 45 Spain protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 46 Spain protein expression market, by product, 2018 - 2030 (USD Million)
• Table 47 Spain protein expression market, by application, 2018 - 2030 (USD Million)
• Table 48 Spain protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 49 Denmark protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 50 Denmark protein expression market, by product, 2018 - 2030 (USD Million)
• Table 51 Denmark protein expression market, by application, 2018 - 2030 (USD Million)
• Table 52 Denmark protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 53 Sweden protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 54 Sweden protein expression market, by product, 2018 - 2030 (USD Million
• Table 55 Sweden protein expression market, by application, 2018 - 2030 (USD Million
• Table 56 Sweden protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 57 Norway protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 58 Norway protein expression market, by product, 2018 - 2030 (USD Million
• Table 59 Norway protein expression market, by application, 2018 - 2030 (USD Million
• Table 60 Norway protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific protein expression market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific protein expression market, by product, 2018 - 2030 (USD Million
• Table 64 Asia Pacific protein expression market, by application, 2018 - 2030 (USD Million
• Table 65 Asia Pacific protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 66 China protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 67 China protein expression market, by product, 2018 - 2030 (USD Million)
• Table 68 China protein expression market, by application, 2018 - 2030 (USD Million)
• Table 69 China protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 70 Japan protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 71 Japan protein expression market, by product, 2018 - 2030 (USD Million)
• Table 72 Japan protein expression market, by application, 2018 - 2030 (USD Million)
• Table 73 Japan protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 74 India protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 75 India protein expression market, by product, 2018 - 2030 (USD Million)
• Table 76 India protein expression market, by application, 2018 - 2030 (USD Million)
• Table 77 India protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 78 South Korea protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 79 South Korea protein expression market, by product, 2018 - 2030 (USD Million)
• Table 80 South Korea protein expression market, by application, 2018 - 2030 (USD Million)
• Table 81 South Korea protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 82 Australia protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 83 Australia protein expression market, by product, 2018 - 2030 (USD Million)
• Table 84 Australia protein expression market, by application, 2018 - 2030 (USD Million)
• Table 85 Australia protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 86 Thailand protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 87 Thailand protein expression market, by product, 2018 - 2030 (USD Million)
• Table 88 Thailand protein expression market, by application 2018 - 2030 (USD Million)
• Table 89 Thailand protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 90 Latin America protein expression market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 92 Latin America protein expression market, by product, 2018 - 2030 (USD Million)
• Table 93 Latin America protein expression market, by application, 2018 - 2030 (USD Million)
• Table 94 Latin America protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 95 Brazil protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 96 Brazil protein expression market, by product, 2018 - 2030 (USD Million)
• Table 97 Brazil protein expression market, by application, 2018 - 2030 (USD Million)
• Table 98 Brazil protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 99 Argentina protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 100 Argentina protein expression market, by product, 2018 - 2030 (USD Million)
• Table 101 Argentina protein expression market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 103 MEA protein expression market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 105 MEA protein expression market, by product, 2018 - 2030 (USD Million)
• Table 106 MEA protein expression market, by application, 2018 - 2030 (USD Million)
• Table 107 MEA protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 108 South Africa protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 109 South Africa protein expression market, by product, 2018 - 2030 (USD Million)
• Table 110 South Africa protein expression market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia protein expression market, by product, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia protein expression market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 116 UAE protein expression market, by product, 2018 - 2030 (USD Million)
• Table 117 UAE protein expression market, by type, 2018 - 2030 (USD Million)
• Table 118 UAE protein expression market, by material, 2018 - 2030 (USD Million)
• Table 119 UAE protein expression market, by size, 2018 - 2030 (USD Million)
• Table 120 UAE protein expression market, by end use, 2018 - 2030 (USD Million)
• Table 121 Kuwait protein expression market, by expression systems, 2018 - 2030 (USD Million)
• Table 122 Kuwait protein expression market, by product, 2018 - 2030 (USD Million)
• Table 123 Kuwait protein expression market, by application, 2018 - 2030 (USD Million)
• Table 124 Kuwait protein expression market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Protein expression market: Market outlook
• Fig. 5 Protein expression market: Segment outlook
• Fig. 6 Protein expression market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Protein expression market driver impact
• Fig. 9 Protein expression market restraint impact
• Fig. 10 Protein expression market: Expression systems outlook and key takeaways
• Fig. 11 Protein expression market: Expression systems movement analysis
• Fig. 12 Prokaryotic market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Mammalian cell market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Insect cell market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Yeast market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Protein expression market: Product outlook and key takeaways
• Fig. 18 Protein expression market: Product movement analysis
• Fig. 19 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Competent cells market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Expression vectors market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Protein expression market: Application outlook and key takeaways
• Fig. 25 Protein expression market: Application movement analysis
• Fig. 26 Therapeutic market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Industrial market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Research market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Protein expression market: End use outlook and key takeaways
• Fig. 30 Protein expression market: End use movement analysis
• Fig. 31 Pharmaceutical and biotechnological companies market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 32 Academic research market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 33 Contract research organizations market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 34 Others market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 35 Global protein expression market: Regional outlook and key takeaways
• Fig. 36 Global protein expression market: Regional movement analysis
• Fig. 37 North America protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 U.S. protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Canada protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Mexico protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Europe protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 UK protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Germany protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 France protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Italy protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Spain protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Denmark protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Sweden protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Norway protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Asia Pacific protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 China protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Japan protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 India protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Thailand protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Korea protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Australia protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Latin America protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Brazil protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Argentina protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Middle East and Africa protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 South Africa protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Saudi Arabia protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 UAE protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Kuwait protein expression market estimates and forecasts, 2018 - 2030 (USD Million)

Protein Expression Market Growth & Trends:

The global protein expression market size is expected to reach USD 6.51 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.22% from 2024 to 2030. The increasing research in proteomics and genomics, the rising incidence of chronic diseases, and escalating demand for biologic products around the globe are enhancing the demand for protein expression, which is likely to drive the market. For instance, in April 2022, in a research published on Frontiers Media S.A., researchers differentially expressed 22 proteins to identify potential diagnostic biomarkers for Multiple Sclerosis (MS).

An increase in R&D investments by the players is estimated to have a considerable impact on the usage of protein expression. In August 2022, the managing director of Biocon Biologics stated in one of his interviews that the overall cost of the R&D is 12-14% of revenues. The investment is essential to build a sustainable portfolio of around 20 biosimilar molecules and the company is anticipated to launch at least once every 1-2 years. The approximate cost of developing these molecules is USD 50-100 million.

Other determinants such as rapid acceleration in the demand for protein therapeutics and government investment in the applications of the protein expression industry are also supporting the market growth. For instance, in May 2022, Proteomics International Laboratories was awarded approximately USD 286,833 funding from the Australian Government under the Medical Research Future Fund (MRFF) initiative. The funding is expected to support the manufacturing of the PromarkerD test in Australia. Such financial assistances are likely to supplement the market growth in the coming years.

The outbreak of the COVID-19 pandemic developed the urge to profile and conduct differential gene expression analyses on COVID-19 patients. Research published in Briefings in Bioinformatics, March 2021, employed the data of protein-drug interaction to identify the prospective drugs for COVID-19. As a result, the usage of the process is projected to upsurge during the COVID-19 pandemic and contribute to market growth.

The growing requirement for personalized therapy and vaccine is expected to be the key factor fueling the market growth during the forecast period. For instance, in January 2022, Amgen announced a collaboration with Generate Biomedicines to discover and develop protein therapeutics for various areas. The companies are estimating the worth of this collaboration around USD 1.9 billion.

The increasing development of recombinant proteins for industrial use, such as the production of food and beverages, is anticipated to boost the use of protein expression in the non-healthcare sector. However, the retail pricings of recombinant proteins for industrial and pharmaceutical uses are drastically different as pharmaceutical proteins are sold for billions of dollars per kg, while industrial proteins for tens of dollars per kg. R&D, clinical trials, and patents are the additional requirements of pharmaceutical proteins.

Protein Expression Market Report Highlights:

• The prokaryotic segment held the largest market share of 41.37% in 2023. Since it is relatively easier to handle and fulfill major purposes in research.
• In 2023, reagents dominated the market with a leading market share of 44.44%. The market consists of mature players such as Agilent Technologies, Inc.
• The therapeutic segment held the highest market share with 52.05% in 2023. Since protein therapeutic poses numerous advantages over other medications.
• The pharmaceutical and biotechnological companies segment held the maximum market share in 2023 with 46.50%.
• North America protein expression market dominated the global market with a 36.11% share in 2023.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Expression Systems
  • 1.2.2. Product
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Protein Expression Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Escalating Demand for Biologics
    • 3.2.1.2. Increasing Investment In R&D
    • 3.2.1.3. Rising Funding By Government For Proteomics And Genomics Research
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent government rules and regulations
• 3.3. Protein Expression Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Protein Expression Market: Expression Systems Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Protein Expression Market Expression Systems Movement Analysis
• 4.3. Global Protein Expression Market Size & Trend Analysis, by Expression Systems, 2018 to 2030 (USD Million)
• 4.4. Prokaryotic
  • 4.4.1. Prokaryotic market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Mammalian Cell
  • 4.5.1. Mammalian cell market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Insect Cell
  • 4.6.1. Insect cell market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Yeast
  • 4.7.1. Yeast market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Protein Expression Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Protein Expression Market Product Movement Analysis
• 5.3. Global Protein Expression Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. Reagents
  • 5.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Competent Cells
  • 5.5.1. Competent cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Expression Vectors
  • 5.6.1. Expression vectors market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Services
  • 5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Instrument
  • 5.8.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Protein Expression Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Protein Expression Market Application Movement Analysis
• 6.3. Global Protein Expression Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Therapeutic
  • 6.4.1. Therapeutic market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Industrial
  • 6.5.1. Industrial market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Research
  • 6.6.1. Research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Protein Expression Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Protein Expression Market End Use Movement Analysis
• 7.3. Global Protein Expression Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical and biotechnological companies
  • 7.4.1. Pharmaceutical and biotechnological companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Academic research
  • 7.5.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Contract research organizations
  • 7.6.1. Contract research organizations market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Protein Expression Market: Regional Estimates & Trend Analysis by Expression Systems, Product, Application, and End Use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Regulatory framework
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Regulatory framework
    • 8.8.5.3. Competitive scenario
    • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Company Profiles/Listing
  • 9.4.1. Agilent Technologies, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Bio-Rad Laboratories
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Edward Lifesciences
    • 9.4.3.1. Company overview
    • 9.4.3.2. Product benchmarking
    • 9.4.3.3. Strategic initiatives
  • 9.4.4. Thermo Fisher Scientific, Inc.
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Merck Millipore
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. New England BioLabs, Inc.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Product benchmarking
    • 9.4.6.3. Strategic initiatives
  • 9.4.7. Promega Corporation
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. QIAGEN
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Takara Bio, Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Oxford Expression Technologies
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Lucigen Corporation
    • 9.4.11.1. Company overview
    • 9.4.11.2. Product benchmarking
    • 9.4.11.3. Strategic initiatives